查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2003934

家用血壓計市場：依連接方式、年齡層和銷售管道分類－2026-2032年全球市場預測

Home Blood Pressure Monitoring Devices Market by Connectivity, Age Group, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，家用血壓監測儀市場價值將達到 33.4 億美元，到 2026 年將成長至 35.7 億美元，到 2032 年將達到 52 億美元，複合年成長率為 6.51%。

主要市場統計數據
基準年 2025 33.4億美元
預計年份：2026年 35.7億美元
預測年份 2032 52億美元
複合年成長率 (%) 6.51%

本介紹部分概述了家庭血壓監測生態系統的發展歷程、消費者醫療保健、數位工具、監管變化以及醫療保健專業人員的採用情況。

家用血壓監測市場正進入一個以技術快速整合、照護模式轉變和消費者參與度提升為特徵的階段。曾經被視為單純醫療設備的血壓監測儀，如今已成為更廣泛的數位健康生態系統的重要組成部分，支持遠端患者監護、慢性病管理和預防性健康促進計畫。醫療專業人員擴大利用患者自身數據來製定個人化的治療方案，而消費者則期望他們的設備能夠提供無縫連接、簡單易用的操作體驗以及檢驗的臨床性能。因此，製造商、經銷商和服務供應商必須確保其產品符合可用性標準、資料互通性要求和臨床工作流程，以維持信譽並實現廣泛應用。

技術、互通性、消費者期望和報銷途徑的變革性變化如何重新定義家庭血壓監測的交付模式。

家用血壓監測領域的變革性轉變反映了感測器技術、連接性、軟體智慧和服務模式等方面的進步融合。如今，具備藍牙和Wi-Fi連接功能的設備與無線和USB設備並存，創造了廣泛的互通性選擇，從而影響測量數據如何流入電子健康記錄和遠端監測平台。隨著科技的進步，消費者的期望也日趨成熟。易用性、隱藏的設計和整合的指導功能正日益影響消費者的購買決策和持續使用。

評估美國計劃於 2025 年調整關稅對供應鏈、籌資策略、零件成本和競爭地位的累積影響。

到2025年，一系列已宣布或實施的關稅調整措施的累積影響正迫使相關人員重新評估籌資策略、合約條款和庫存管理。推高壓力感測器、電子模組和包裝材料等進口零件成本的關稅可能會提高整體成本結構，並擠壓依賴國際採購的製造商的利潤空間。為此，各公司正在探索近岸外包、雙重採購和供應商多元化等策略，以降低對單一國家依賴的風險並縮短物流前置作業時間。

關鍵細分洞察揭示了設備連接性、分銷管道和年齡層滲透模式如何影響產品開發和商業化路徑。

細分市場分析揭示了部署模式和產品優先順序的細微差異，這些差異應指南產品開發和市場進入策略。依連接方式，市場可分為藍牙、無線連接、USB 和 Wi-Fi 四種配置。藍牙裝置在低功耗和智慧型手機整合之間保持平衡，而支援直接雲端上傳的 Wi-Fi 選項則更受居家照護環境的青睞。無線連接型號仍然適用於價格敏感型買家和以簡易性為首要考慮因素的環境，而 USB 解決方案則為偏好有線數據傳輸和本地備份的用戶提供了一種混合選擇。

影響家庭血壓監測設備引進、監管和分銷的美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和競爭格局。

區域趨勢對美洲、歐洲、中東和非洲以及亞太地區的監管要求、分銷策略和用戶偏好有顯著影響。在美洲，醫保報銷機制和遠距遠端醫療計畫的擴展提高了人們對連網設備的興趣，而分銷網路則呈現全國連鎖藥局融合和電子商務蓬勃發展的趨勢。一些司法管轄區的過渡性監管指南強調設備檢驗和資料保護，從而影響產品功效聲明和標籤策略。在歐洲、中東和非洲，由於司法管轄區之間的碎片化，需要製定區域性監管措施，尤其是在醫療設備分類和資料居住法規方面。相關人員通常採取區域性方法，優先考慮統一的臨床證據和靈活的隱私管理。

家用血壓監測領域主要企業的概況和策略趨勢，這些企業在創新、夥伴關係、監管合規和市場擴張方面發揮重要作用。

主要企業正採用差異化策略，在產品、軟體和服務層面獲取價值。一些企業強調嚴格的臨床檢驗和認證，以建立臨床醫生的信任並促進醫療機構的採納；而另一些企業則專注於打造無縫的消費者體驗、提供訂閱服務以及建立零售夥伴關係關係，以拓展直接面對消費者 (D2C) 的銷售管道。與遠端醫療平台、慢性病管理服務提供者和電子健康記錄 (EHR) 供應商建立策略夥伴關係十分普遍，這使得設備製造商能夠將其硬體整合到更廣泛的醫療服務路徑中，並透過整合服務提高用戶留存率。

為產業領導者提供切實可行的建議，以加速創新、確保有韌性的供應鏈、與臨床醫生合作以及最佳化以消費者為中心的服務交付。

產業領導者應優先考慮一系列切實可行的舉措，將洞察轉化為可衡量的成果。首先，透過實施安全API和遵守臨床數據標準，投資於設備互通性，使設備能夠輕鬆整合到遠端醫療平台和電子健康記錄。其次，設計模組化產品系列，提供諸如離線、藍牙、USB和Wi-Fi等多種連接方式，從而最佳化分銷和定價策略，以滿足不同消費群體和銷售管道的需求。第三，透過供應商多元化、盡可能近岸外包以及提高零件前置作業時間的透明度，增強供應鏈韌性，從而減輕關稅和物流衝擊的影響。

本文檔概述了本研究採用的嚴格調查方法，包括資料收集、一級和二級調查的整合、檢驗通訊協定和分析架構。

本研究採用混合方法，結合一手質性訪談、二手文獻整合和技術審查，全面涵蓋技術、臨床和商業性方面。一手研究包括對臨床醫生、採購負責人、通路合作夥伴和產品經理進行結構化訪談，以收集關於可用性、整合障礙和採購標準的第一手觀點。二手研究則利用監管指南、醫療設備標籤檢視、標準文件和企業資訊披露來驗證相關聲明，並明確臨床認可的檢驗要求。

總結策略見解，幫助相關人員將技術趨勢、監管趨勢和消費行為轉化為實際的商業行動。

總之，家用血壓監測產業正因互聯技術的進步、消費者對家用環境下臨床級性能日益成長的期望，以及在貿易政策變化背景下對更具韌性的供應鏈策略的需求而發生變革。那些能夠使產品設計符合互通性標準、投資於成人、老年人和兒童等不同人群的實際檢驗，並採用考慮當地實際情況的分銷相關人員相關者，將更有利於獲取長期價值。同樣重要的是，企業需要能夠透過將線上直接互動與實體藥局和專賣店結合來調整經營模式，以滿足多樣化的消費者需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：家用血壓監測器市場：連結性

  • Bluetooth
  • 斷開連接
  • USB
  • Wi-Fi

第9章：家用血壓計市場：依年齡層別分類

  • 成人版
  • 老年人
  • 兒童

第10章：家用血壓計市場：依通路分類

  • 線上管道
    • 品牌官方網站
    • EC市場
  • 離線

第11章：家用血壓計市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章：家用血壓計市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：家用血壓計市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國家用血壓計市場

第15章：中國家用血壓計市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • A&D Company, Limited
  • Beurer GmbH
  • Choicemmed（Dalian）Co., Ltd.
  • Citizen Holdings Co., Ltd.
  • Contec Medical Systems Co., Ltd.
  • ForaCare Inc.
  • GE HealthCare Technologies Inc.
  • iHealth Labs Inc.
  • iProven Healthcare
  • Microlife Corporation
  • Omron Healthcare Co., Ltd.
  • Panasonic Corporation
  • Rossmax International Ltd.
  • Shenzhen Jumper Medical Equipment Co., Ltd.
  • SunTech Medical, Inc.
  • Welch Allyn
Product Code: MRR-3E376243AC7A

The Home Blood Pressure Monitoring Devices Market was valued at USD 3.34 billion in 2025 and is projected to grow to USD 3.57 billion in 2026, with a CAGR of 6.51%, reaching USD 5.20 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.34 billion
Estimated Year [2026] USD 3.57 billion
Forecast Year [2032] USD 5.20 billion
CAGR (%) 6.51%

Introduction framing the evolving home blood pressure monitoring ecosystem, converging consumer healthcare, digital tools, regulatory shifts and clinician adoption

The home blood pressure monitoring landscape has entered a phase characterized by rapid technological integration, shifting care models, and rising consumer engagement. Devices once considered simple medical instruments are now components of broader digital health ecosystems that support remote patient monitoring, chronic care management, and preventative wellness programs. Clinicians increasingly rely on patient-generated data to inform treatment adjustments, while consumers expect devices to deliver seamless connectivity, clear usability, and validated clinical performance. Consequently, manufacturers, distributors, and service providers must align product features with usability standards, data interoperability requirements, and clinical workflows to maintain credibility and adoption.

At the same time, payors and regulators are refining expectations around device accuracy, data security, and evidence generation. As a result, stakeholders must manage a complex intersection of design, evidence generation, and market access considerations. This introduction frames the report by highlighting how digital capabilities, regulatory scrutiny, and evolving reimbursement mindsets collectively influence product roadmaps and channel strategies. The remainder of the document explores these dynamics in detail, translating them into strategic guidance that helps stakeholders prioritize investments, adapt commercialization approaches, and sustain competitive differentiation in a rapidly modernizing healthcare environment.

How transformative shifts in technology, interoperability, consumer expectations and reimbursement pathways are redefining home blood pressure monitoring delivery models

Transformative shifts in the home blood pressure monitoring sector reflect a convergence of advances in sensor technology, connectivity, software intelligence, and service models. Devices equipped with Bluetooth and Wi-Fi connectivity now coexist with nonconnected and USB-enabled units, creating a spectrum of interoperability options that affect how measured data flows into electronic health records and remote monitoring platforms. Parallel to technological evolution, consumer expectations have matured: ease of use, unobtrusive form factors, and integrated coaching features increasingly shape purchase decisions and adherence.

Interoperability standards and developer ecosystems are becoming critical; manufacturers who design for open APIs and secure data exchange can unlock partnerships with digital therapeutics, telehealth providers, and chronic care management platforms. Moreover, clinical acceptance is influenced by evidence of accuracy in real-world settings and the capacity to integrate patient-generated data into clinician workflows without creating administrative burden. Policy shifts, including updates to device classification and data protection requirements, further incentivize manufacturers to invest in clinical validation and privacy engineering. Taken together, these shifts are not isolated; they interact to reshape vendor strategies, influence distribution decisions, and redefine expectations for post-market support and patient engagement.

Assessing the cumulative implications of United States tariff adjustments designated for 2025 on supply chains, sourcing strategies, component costs and competitive positioning

The cumulative implications of tariff adjustments announced or implemented for 2025 are prompting stakeholders to reassess sourcing strategies, contract terms, and inventory management across the value chain. Tariffs that increase costs for imported components such as pressure sensors, electronic modules, and packaging materials can elevate landed cost structures and compress margins for manufacturers that rely on internationally sourced inputs. In response, organizations are exploring nearshoring, dual-sourcing, and supplier diversification to reduce exposure to single-country risk and to shorten logistical lead times.

In addition, procurement teams are negotiating longer-term agreements with tier-one suppliers and accelerating qualification of alternate vendors to preserve production continuity. Distributors and retailers are evaluating pricing models and promotional strategies to mitigate pass-through effects to end consumers while preserving demand elasticity. Regulatory compliance and supply chain transparency become more important as tariffs interact with trade documentation and customs procedures, increasing the need for robust trade compliance capabilities. Overall, the tariff environment for 2025 is acting as a catalyst for supply chain resilience investments and strategic sourcing realignment across manufacturers and channel partners.

Key segmentation insights revealing how device connectivity, distribution channels and age-specific adoption patterns are shaping product development and commercialization paths

Segmentation analysis reveals nuanced adoption patterns and product priorities that should guide product development and go-to-market strategies. Based on connectivity, the market spans Bluetooth, nonconnected, USB, and Wi-Fi configurations; Bluetooth-enabled devices continue to balance low power consumption with smartphone integration, while Wi-Fi options facilitate direct cloud uploads and are favored in institutional home-care setups. Nonconnected models remain relevant for price-sensitive buyers and settings where simplicity is paramount, and USB solutions provide a hybrid option for users who prefer tethered data transfer and local backups.

Based on distribution channel, the landscape includes online channels, pharmacy channels, and specialty retail; the online channel is further differentiated by brand websites and e-commerce marketplaces that offer direct-to-consumer engagement and subscription models, whereas pharmacy channels encompass brick-and-mortar pharmacies including chain and independent outlets that provide pharmacist counseling and point-of-sale trust. Specialty retail, which comprises department stores and medical stores, targets consumers seeking premium, lifestyle-oriented devices or clinically oriented sales support. Based on age group, adoption patterns vary across adult, geriatric, and pediatric segments; geriatric users prioritize simplicity, cuff fit considerations, and caregiver integration, adults value app features and insights that support lifestyle changes, and pediatric use cases require specialized cuff sizing, validation protocols, and clinician partnerships. Synthesizing these segmentation lenses highlights the importance of modular product architectures and channel-tailored value propositions to address diverse user needs and purchasing behaviors.

Regional dynamics and competitive contours across the Americas, Europe Middle East & Africa and Asia-Pacific that influence adoption, regulation and distribution of HBPM devices

Regional dynamics exert a powerful influence on regulatory requirements, distribution strategies, and user preferences across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, reimbursement frameworks and growing telehealth programs have bolstered interest in connected devices, while distribution networks blend national pharmacy chains with robust e-commerce adoption. Transitional regulatory guidance in some jurisdictions emphasizes device validation and data protection, shaping product claims and labeling strategies. In Europe, Middle East & Africa, fragmentation across jurisdictions requires localized regulatory navigation, particularly around medical device classification and data residency rules; stakeholders often adopt a regionalized approach that prioritizes harmonized clinical evidence and adaptable privacy controls.

Asia-Pacific presents a heterogeneous mix of advanced digital adoption in urban centers and cost-sensitive demand in emerging markets; manufacturers often pursue tiered product portfolios and local partnerships to reconcile premium feature sets with affordability. Across regions, channel dynamics differ: the pharmacy and specialty retail channels drive in-person counseling and credibility, while online channels accelerate reach and subscription models. Consequently, a regionally informed approach to regulatory evidence generation, distribution partnerships, and pricing architecture is essential for commercial success and sustained user engagement.

Profiles of key companies and strategic behaviors that drive innovation, partnerships, regulatory navigation and channel expansion within the home blood pressure monitoring sector

Key companies are deploying differentiated strategies to capture value across product, software, and service dimensions. Some firms emphasize rigorous clinical validation and certification to build clinician trust and institutional adoption, while others focus on seamless consumer experiences, subscription services, and retail partnerships to scale direct-to-consumer traction. Strategic partnerships with telehealth platforms, chronic care management providers, and electronic health record vendors are common, enabling device makers to embed their hardware within broader care pathways and to enhance stickiness through integrated services.

R&D investment is concentrated on improving cuff ergonomics, reducing measurement variability, and advancing algorithmic compensation for motion and arrhythmias, which enhances clinical usability. On the commercial side, companies are expanding distribution footprints by blending online direct sales with pharmacy and specialty retail placements, and they are experimenting with bundled offerings that include coaching or clinical review. Competitive behavior also includes vertical integration moves, selective acquisitions, and licensing of software modules to accelerate time to market. Collectively, these strategic patterns illustrate how product innovation, evidence generation, and channel orchestration shape competitive positioning in the sector.

Actionable recommendations for industry leaders to accelerate innovation, secure resilient supply chains, engage clinicians and optimize consumer-centric service offerings

Industry leaders should prioritize a set of practical actions to translate insights into measurable outcomes. First, invest in device interoperability by implementing secure APIs and adherence to clinical data standards so devices can readily integrate with telehealth platforms and electronic health records. Second, design modular portfolios that offer connectivity tiers-nonconnected, Bluetooth, USB, and Wi-Fi-so distribution and pricing strategies can be tailored to consumer segments and channel requirements. Third, strengthen supply chain resilience through supplier diversification, nearshoring where feasible, and enhanced visibility into component lead times to mitigate tariff and logistic shocks.

Furthermore, allocate resources to clinical validation in real-world settings and to usability testing across adult, geriatric, and pediatric cohorts to demonstrate both accuracy and user acceptability. Expand commercial models by combining direct online engagement with pharmacy and specialty retail partnerships, and explore subscription services that bundle device access with coaching or clinician review. Finally, adopt privacy-by-design and robust cyber security practices to build trust with clinicians, payors, and consumers. Implementing these recommendations will help organizations reduce commercial friction, improve adoption, and position offerings for long-term integration into care delivery.

Rigorous research methodology outlining data collection, primary and secondary research synthesis, validation protocols and analytical frameworks employed in this study

This study employed a mixed-methods approach combining primary qualitative interviews, secondary literature synthesis, and technical review to ensure comprehensive coverage of technological, clinical, and commercial dimensions. Primary research included structured interviews with clinicians, procurement officers, channel partners, and product leaders to capture front-line perspectives on usability, integration hurdles, and purchasing criteria. Secondary research drew on regulatory guidance, device labeling, standards documentation, and company disclosures to validate claims and to map evidence requirements for clinical acceptance.

Analytical procedures included comparative feature mapping across connectivity types and distribution channels, scenario analysis exploring supply chain adjustments to tariff changes, and synthesis of regional regulatory variations to inform commercialization approaches. Validation protocols incorporated cross-referencing interview insights with published standards and selected product technical sheets to ensure factual consistency. The methodology prioritized transparency and replicability by documenting interview protocols, source selection criteria, and analytical assumptions within the report appendices, enabling readers to understand the provenance of key conclusions and to adapt the approach for their own internal analyses.

Conclusion synthesizing strategic takeaways for stakeholders to translate technology trends, regulatory signals and consumer behaviors into practical business actions

In conclusion, the home blood pressure monitoring sector is being reshaped by advances in connectivity, rising expectations for clinical-grade performance in home settings, and the need for resilient supply chain strategies in the face of trade policy shifts. Stakeholders that align product design with interoperability standards, invest in real-world validation across adult, geriatric, and pediatric populations, and adopt regionally nuanced distribution approaches will be better positioned to capture long-term value. Equally important is the ability to adapt commercial models by blending direct online engagement with pharmacy and specialty retail presence to meet diverse consumer needs.

Sustained success will depend on integrating privacy and security into device lifecycles, forging partnerships with clinical and digital health platforms, and maintaining flexible sourcing strategies that mitigate tariff exposure. The synthesis provided here is intended to support informed decision making, accelerate commercially relevant innovation, and guide operational investments that enable devices to become enduring components of patient care pathways. For organizations ready to translate these insights into action, the next step is a focused review of device portfolios, evidence development plans, and channel strategies to prioritize initiatives with the highest strategic impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Home Blood Pressure Monitoring Devices Market, by Connectivity

  • 8.1. Bluetooth
  • 8.2. Nonconnected
  • 8.3. Usb
  • 8.4. Wi-Fi

9. Home Blood Pressure Monitoring Devices Market, by Age Group

  • 9.1. Adult
  • 9.2. Geriatric
  • 9.3. Pediatric

10. Home Blood Pressure Monitoring Devices Market, by Distribution Channel

  • 10.1. Online Channel
    • 10.1.1. Brand Website
    • 10.1.2. E-Commerce Marketplace
  • 10.2. Offline

11. Home Blood Pressure Monitoring Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Home Blood Pressure Monitoring Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Home Blood Pressure Monitoring Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Home Blood Pressure Monitoring Devices Market

15. China Home Blood Pressure Monitoring Devices Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. A&D Company, Limited
  • 16.6. Beurer GmbH
  • 16.7. Choicemmed (Dalian) Co., Ltd.
  • 16.8. Citizen Holdings Co., Ltd.
  • 16.9. Contec Medical Systems Co., Ltd.
  • 16.10. ForaCare Inc.
  • 16.11. GE HealthCare Technologies Inc.
  • 16.12. iHealth Labs Inc.
  • 16.13. iProven Healthcare
  • 16.14. Microlife Corporation
  • 16.15. Omron Healthcare Co., Ltd.
  • 16.16. Panasonic Corporation
  • 16.17. Rossmax International Ltd.
  • 16.18. Shenzhen Jumper Medical Equipment Co., Ltd.
  • 16.19. SunTech Medical, Inc.
  • 16.20. Welch Allyn

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY NONCONNECTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY NONCONNECTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY NONCONNECTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY USB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY USB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY USB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY WI-FI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY WI-FI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY WI-FI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY BRAND WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY BRAND WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY BRAND WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY E-COMMERCE MARKETPLACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY E-COMMERCE MARKETPLACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY E-COMMERCE MARKETPLACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. AMERICAS HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 45. NORTH AMERICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. NORTH AMERICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 50. LATIN AMERICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. LATIN AMERICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 52. LATIN AMERICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. MIDDLE EAST HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. MIDDLE EAST HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 67. MIDDLE EAST HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. MIDDLE EAST HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 69. MIDDLE EAST HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. AFRICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. AFRICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 72. AFRICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. AFRICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. AFRICA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. ASEAN HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. ASEAN HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 83. ASEAN HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. ASEAN HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. ASEAN HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. GCC HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GCC HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 88. GCC HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GCC HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. GCC HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPEAN UNION HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPEAN UNION HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPEAN UNION HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPEAN UNION HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPEAN UNION HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. BRICS HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. BRICS HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 98. BRICS HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. BRICS HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. BRICS HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. G7 HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. G7 HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 103. G7 HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. G7 HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. G7 HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. NATO HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NATO HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 108. NATO HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. NATO HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. NATO HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. UNITED STATES HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. UNITED STATES HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 114. UNITED STATES HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. UNITED STATES HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. UNITED STATES HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. CHINA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. CHINA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 119. CHINA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. CHINA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. CHINA HOME BLOOD PRESSURE MONITORING DEVICES MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)